PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-Mar-2026 Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel Businesswire
03-Mar-2026 Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders Businesswire
03-Mar-2026 Konovo Names Jessica Santos as Chief Compliance and Privacy Officer Businesswire
03-Mar-2026 Antiverse Raises $9.3M Series A to Develop Antibodies for Undruggable Disease Targets and Announces Research Agreement with the Cystic Fibrosis Foundation Businesswire
03-Mar-2026 NorthSea Therapeutics Announces Achievement of Key Regulatory Milestones for Orziloben Businesswire
03-Mar-2026 Syntis Bio Announces First Patient Dosed in Phase 1/1b Clinical Trial of SYNT-101 in Obesity and Key Leadership Additions Businesswire
03-Mar-2026 Kivu Bioscience Appoints Brunilda Shtylla as Chief Business Officer Businesswire
03-Mar-2026 Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD Businesswire
03-Mar-2026 EU Regulatory Reforms and Global Healthcare Innovation to be Focus of DIA Europe 2026 Businesswire
03-Mar-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-Mar-2026 Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference Businesswire
03-Mar-2026 PepGen to Participate in the Leerink Global Healthcare Conference Businesswire
03-Mar-2026 Phreesia Network Solutions Launches ProviderConnect, a Pioneering Offering to Engage Clinicians When It Matters Most Businesswire
03-Mar-2026 NHS Confederation and NHS Providers announce new merged membership organisation NHS Confederation
03-Mar-2026 AI in Medical Writing Certification Program Launched by TrialAssure to Support Greater Adoption Across Pharma and Biotech TrialAssure
03-Mar-2026 IMPACT-O study highlights gaps in diagnosis recording and management of overweight and obesity Eli Lilly and Company
03-Mar-2026 BioTalent Canada Breaks Barriers in Opening Applications for 2026 I.D.E.A.L. Scholarship™ Businesswire
03-Mar-2026 Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray) Businesswire
03-Mar-2026 Dusk to Dawn Urgent Care Celebrates 25 Years of Service to Southern California ACCESS Newswire
03-Mar-2026 RecovryAI Announces FDA Breakthrough Device Designation for Patient-Facing Clinical AI Businesswire